A pharmaceutical company priced a life-saving drug at $2.1M per treatment while production cost is under $200, capturing $1.9M per patient in monopoly rent.

Submitted by HealthcareWatcher May 24, 2026 Estimated range: $1M–$10M+ per patient

Community Evaluations (8)

Fatima Hassan $1.5M–$5M per patient

R&D cost amortization vs monopoly rent extraction. Focus on access harm.

PharmaWatch $500K–$3M per patient

Production cost × fair margin methodology.

Daniel Rivers $10M–$50M per patient

DALY valuation × patient population. Highest estimate.

Priya Patel $2M–$8M per patient

Market monopoly pricing analysis.

GlobalHealthWatch $1M–$4M per patient

WHO pricing model comparison.

HealthEquity $3M–$12M per patient

Quality-adjusted life years × ability to pay methodology.

TreatmentAccess $5M–$20M per patient

Global health system cost breakdown methodology.

Fatima Hassan $2M–$7M per patient

Second opinion — refined calculation.